Cell and Gene Therapy Cold Chain Logistics Innovators and Market Trends Analysis

Top Companies in the Market and Recent Innovation

• Cryoport, Inc.
• World Courier
• Marken
• Catalent Cell & Gene Therapy Logistics
• Lonza Bioscience Logistics
• Thermo Fisher Scientific
• BioLife Solutions
• TrakCel
• Brooks Life Sciences
• Be The Match BioTherapies
• QuickSTAT 
• DHL Life Sciences & Healthcare
• FedEx Custom Critical Healthcare Solutions
• United Parcel Service
• McKesson Specialty Health
• Aramex Life Science Logistics
• CryoStore Ltd. 
• Integra LifeSciences Cold Storage Solutions
• Peli BioThermal
• Savsu Technologies

Market Growth

The global cell and gene therapy cold chain logistics market size is calculated at US$ 1.89 billion in 2024, grew to US$ 2.19 billion in 2025, and is projected to reach around US$ 8.06 billion by 2034. The market is expanding at a CAGR of 15.64% between 2025 and 2034.

What are the Major Market Trends?

Growing collaborations: Due to the growing use of CGT, there is a rise in the demand for cell and gene therapy cold chain logistics. This is increasing the collaboration among the companies and CDMOs to enhance their development. Similarly, the collaboration among the companies and logistics providers is also increasing.

For instance,

• In July 2025, a manufacturing collaboration was announced between ViroCell Biologics, which is a viral vector contract development and manufacturing organisation (“CDMO”), and AvenCell Therapeutics, Inc., which is a leading clinical-stage cell therapy company. An investigational CD19/CD20 dual-targeted cell therapy, which is AVC-203 for the treatment of autoimmune diseases and B-cell malignancies, will be manufactured by this collaboration.
• In September 2024, to offer completely merged logistics and manufacturing services to pharmaceutical and biotechnology companies, a collaboration between Cryoport, Inc. and SK Pharmteco was announced. The contract manufacturing of both cell and gene therapy and small molecule products of SK Pharmteco will be backed by Cryoport in this collaboration.

Market Value Chain Analysis

R&D

To provide safe and effective delivery of temperature-sensitive and fragile therapeutics, the development of innovative thermal packaging, advanced cryopreservation techniques, smart tracking, and monitoring systems, along with the optimization of supply chain models, will be the focus for cell and gene therapy cold chain logistics R&D.

Key Players: Marken, Cryoport, QuickSTAT, World Courier, Biocair

Clinical Trials and Regulatory Approvals

The clinical trials and regulatory approvals of cell and gene therapy cold chain logistics include the validation of temperature control, real-time monitoring, and packaging solutions.

Key Players: Marken, Cryoport, World Courier, Biocair

Patient Support and Services

To offer personalized and end-to-end guidance to the patient with emotional counselling, dedicated case managers, and financial assistance programs for the navigation of time-sensitive and complex logistics for the treatment are included in the patient support and services of cell and gene therapy cold chain logistics.

Key Players: Marken, Cryoport, Cencora, TrakCel, and Vineti, Cardinal Health

What is the Latest Announcement by an Industry Leader in the Market?

In January 2025, after revealing the Cryoport Express®â€¯Cryogenic HV3 Shipping System ("HV3"), the CEO of Cryoport, Jerrell Shelton, stated that to meet the needs of their patients and clients, they are continuously evolving their solution and are committed to predicting industry challenges. The patient access to vital cell therapies in remote areas and smaller cities is being enhanced, with the introduction of Cryoport Express®â€¯Cryogenic HV3 Shipping System, which in turn will enhance the patient outcomes.

Recent Developments in the Market

• In August 2025, plans to launch an online logistics platform are being made by the Pharmaceuticals Export Promotion Council of India (Pharmexcil). This platform will focus on enhancing the service quality by providing integrated compliance management, real-time tracking, a feedback mechanism, route optimization, competitive pricing through bidding models, digital document exchange, and booking of value-added services such as warehousing and insurance.
• In February 2025, to revolutionize cold chain compliance in life sciences and pharmaceutical industries, a platform that will bring together academia, industry, social, and government bodies was launched by the National Accreditation Body for Cold Chain Management (NAB-CCM). The individuals/companies in the field of cold chain management will receive professional training, ethical practices, and structured education in this initiative.

Become a valued research partner with us, please feel free to contact us at sales@towardshealthcare.com